FDA inspection
Samchundang Pharm Co., Ltd.: FDA inspection ending May 19, 2026
FDA inspection 1322344 · Official Action Indicated (OAI) · Hwaseong
Key facts
| Inspection ID | 1322344 |
|---|---|
| Firm | Samchundang Pharm Co., Ltd. |
| FEI number | 3008425092 |
| Address | Hyangnam Pharmaceutical Industries Complex, 71 Jeyakgongdan2-Gil; Hyangnam-Eup |
| City | Hwaseong |
| Country | Korea (the Republic of) |
| Fiscal year | 2026 |
| Inspection end date | May 19, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data